Industry leaders laud UP’s governance, investment climate at first pharma conclave

Top executives from leading domestic and global pharmaceutical companies on Tuesday praised Uttar Pradesh’s improving governance framework, law-and-order situation and investment-friendly environment at the state’s first-ever pharma conclave held here.

According to an official statement, industry leaders said Uttar Pradesh has witnessed significant foundational and structural reforms in recent years, which have created a conducive ecosystem for large-scale investments and sustained industrial growth, particularly in the pharmaceutical sector.

Participants highlighted that improved policy stability, streamlined regulatory processes and enhanced infrastructure have strengthened investor confidence in the state. They also noted that better governance and law-and-order conditions have played a key role in attracting both domestic and international pharma companies.

Rajya Sabha member and Ramco Group Chairman Ayodhya Rami Reddy lauded Chief Minister Yogi Adityanath’s leadership, describing it as an “outstanding commitment to the nation and society.” He said the state’s clear vision and decisive governance have helped position Uttar Pradesh as an emerging hub for pharmaceutical manufacturing and innovation.

The conclave marked a significant step in the state government’s efforts to engage with industry stakeholders and showcase Uttar Pradesh’s potential as a preferred destination for pharma investments, officials said.